Ayman El‐Kattan
- Oncology top 2%
- Pharmacology top 0.2%
- Molecular Biology top 10%
- Pediatrics, Perinatology and Child Health top 2%
- Pharmaceutical Science top 0.5%
- Co-authors
- Manthena V. S. VarmaC. S. AsbillBozena MichniakStefanus J. SteynYurong LaiCharles J. RotterMatthew D. TroutmanBo Feng
- Topics
- Drug Transport and Resistance Mechanisms (31 papers)Pharmacological Effects and Toxicity Studies (19 papers)Pharmacogenetics and Drug Metabolism (17 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Ayman El‐Kattan
53 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 123
- Oncology 1.3k
- Pharmacology 1.0k
- Molecular Biology 697
- Pediatrics, Perinatology and Child Health 666
- Pharmaceutical Science 577
Countries citing papers authored by Ayman El‐Kattan
This map shows the geographic impact of Ayman El‐Kattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman El‐Kattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman El‐Kattan more than expected).
Fields of papers citing papers by Ayman El‐Kattan
This network shows the impact of papers produced by Ayman El‐Kattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman El‐Kattan. The network helps show where Ayman El‐Kattan may publish in the future.
Co-authorship network of co-authors of Ayman El‐Kattan
This figure shows the co-authorship network connecting the top 25 collaborators of Ayman El‐Kattan. A scholar is included among the top collaborators of Ayman El‐Kattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman El‐Kattan. Ayman El‐Kattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 32 | |
| 3 | 24 | |
| 4 | 223 | |
| 5 | 4 | |
| 6 | 52 | |
| 7 | 39 | |
| 8 | 54 | |
| 9 | 45 | |
| 10 | 20 | |
| 11 | 186 | |
| 12 | 31 | |
| 13 | 35 | |
| 14 | 45 | |
| 15 | 13 | |
| 16 | 74 | |
| 17 | 106 | |
| 18 | 99 | |
| 19 | 47 | |
| 20 | 56 |
About Ayman El‐Kattan
Ayman El‐Kattan is a scholar working on Pharmacology, Pharmaceutical Science and Oncology, having authored 53 papers that have together received 3.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (31 papers), Pharmacological Effects and Toxicity Studies (19 papers) and Pharmacogenetics and Drug Metabolism (17 papers). The work is most often cited by research in Pharmacology (1.0k citations), Pharmaceutical Science (577 citations) and Oncology (1.3k citations). Ayman El‐Kattan has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Manthena V. S. Varma, C. S. Asbill, Bozena Michniak, Stefanus J. Steyn, Yurong Lai, Charles J. Rotter, Matthew D. Troutman, Bo Feng, Katherine S. Fenner and Charlotte Allerton. Their work appears in journals such as Analytical Chemistry, Advanced Drug Delivery Reviews and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.